Three consecutive earnings beats suggest improving execution, but the stock is trading above its near-term price target with RSI at 81 and weak underlying growth — the current entry geometry favors waiting for a pullback before committing new capital.
Thesis pillars
- Earnings Beat Recovery↑Improving
- Above Target No Upside↓Deteriorating
- Fcf Quality Concern→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 24, 2026· older than 90 days
Henry Schein, Inc. (HSIC) Stock Analysis
Breakout setup
Healthcare · Medical Distribution
Hold if already holding. Not a fresh buy at $88.24, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (4.3% away).
Henry Schein distributes health care products and services to more than one million dental and medical customers across 34 countries through Global Distribution and Value-Added Services (84.5% of net sales in 2025), Global Specialty Products (11.7%), and Global Technology... Read more
Hold if already holding. Not a fresh buy at $88.24, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (4.3% away). Chart setup: Golden cross, above all MAs, RSI 53, MACD bullish. Mixed signals. Hold existing position. Score 5.6/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst 0.50, earnings proximity 110d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
About Henry Schein, Inc.
About Henry Schein, Inc.
Henry Schein served more than one million dental and medical customers across 34 countries and territories in fiscal 2025, with the Dental category representing 52.0% of consolidated net sales and Medical 32.5%. The company's three segments—Global Distribution and Value-Added Services (84.5% of net sales), Global Specialty Products (11.7%), and Global Technology (5.1%)—employed over 25,000 people at year-end, with 52% of the workforce outside the United States. Henry Schein operates 38 distribution centers and 17 manufacturing facilities globally.
Henry Schein generates revenue from consumable and equipment distribution to dental and medical practitioners, supplemented by specialty product manufacturing (dental implants, endodontics, orthodontics, and orthopedics) and practice management software. The Global Technology segment had approximately 95,000 active practice users and 324,000 consumers at December 27, 2025. In U.S. dental distribution, primary competitors are Patterson Dental (a division of Patterson Companies) and Benco Dental Supply; in U.S. medical distribution, McKesson Corporation and Medline Industries. Outside the U.S., the company positions itself as the only global dental distributor to practices, competing against regional players including Cadence Group, DD Group, Lifco AB, and Planmeca Group. In fiscal 2025, the top 10 Global Distribution and Value-Added Services suppliers accounted for approximately 24% of aggregate purchases and the single largest supplier 4%, with the company characterizing no single supplier as material. Supplier rebates tied to volume growth targets represent an additional income stream subject to competitive and supply conditions.
Show full overview
Henry Schein's distribution model faces structural headwinds from online price transparency and potential regulatory reimbursement shifts. The 10-K notes that potential adoption of the One Big Beautiful Bill Act could affect Medicare and Medicaid eligibility, which may impact practitioner demand for distributed products. On cybersecurity, an October 2023 cyberattack disrupted North American and European dental and medical distribution operations, with residual financial impact extending into fiscal 2024—the filing acknowledges this may mark the company as a more vulnerable future target. In January 2025, funds affiliated with KKR invested $250 million at approximately $76.10 per share under a Strategic Partnership Agreement permitting KKR to acquire up to 19.9% of outstanding shares, a large-block counterparty relationship the filing acknowledges could create unintended conflicts or uncertainty about strategic direction.
See also: Healthcare · Medical Distribution
From Henry Schein, Inc.'s most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated Nov 4, 2026Recent Developments — Henry Schein, Inc.
Latest news
- NEWS UBS Maintains Neutral on Henry Schein, Raises Price Target to $95 — benzinga Nov 4, 2026 positive
- NEWS Henry Schein (HSIC) Could Be 16% Undervalued On Higher Margin Growth Story - Simply Wall St — Simply Wall St Oct 27, 2026 positive
- NEWS Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance — Yahoo Finance Oct 27, 2026 negative
- NEWS Henry Schein to Report Q3 Earnings: Here's What You Should Know - TradingView — TradingView Oct 27, 2026 neutral
- NEWS Evercore ISI Keeps Their Buy Rating on Henry Schein (HSIC) - The Globe and Mail — The Globe and Mail Aug 5, 2026 neutral
Latest item Nov 4, 2026 · Generated 2026-11-05T11:49:10Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $88.24, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (4.3% away). Chart setup: Golden cross, above all MAs, RSI 53, MACD bullish. Mixed signals. Hold existing position. Analyst target $87.18 reached (−1.2%), stop $83.26 (−6.0%), A.R:R -0.1:1. Score 5.6/10, moderate confidence.
Analyst target $87.18 reached (−1.2% from $88.24); no take-profit level is published. Analyst target $87.18 reached (−1.2%), stop $83.26 (−6.0%), A.R:R -0.1:1. Stop-loss: $83.26.
Analyst target reached - limited upside remaining; Near 52-week high (4.3% away); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1).
Henry Schein, Inc. trades at a P/E of 24.2 (forward 14.7). TrendMatrix value score: 5.9/10. Verdict: Hold.
24 analysts rate HSIC, with a consensus score of 3.8/5. 15 analysts publish price targets averaging $97.
What does Henry Schein, Inc. do?Henry Schein distributes health care products and services to more than one million dental and medical customers across...
Henry Schein distributes health care products and services to more than one million dental and medical customers across 34 countries through Global Distribution and Value-Added Services (84.5% of net sales in 2025), Global Specialty Products (11.7%), and Global Technology (5.1%). Revenue is generated through consumable and equipment sales, practice management software serving 95,000 active practices, repair services, and financial services to office-based practitioners. The company employs over 25,000 people and ships approximately 150,000 cartons daily from 38 distribution centers.